Clinical Trial: Contact Lens-Wearing Dry Eye Subjects Who Are Treated With Acoltremon 0.003%

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848373) titled 'Contact Lens-Wearing Dry Eye Subjects Who Are Treated With Acoltremon 0.003%' on Sept. 24.

Brief Summary: Dry Eye Disease is a multifaceted condition which has symptoms such as eye dryness, burning, and stinging sensation in the eyes. As well as clinical diagnosis such as a decreased ability to create tear film. Despite improvements in Contact Lenses (CL) DED still is responsible for a large percentage of CL dropouts due to discomfort. Thus, the purpose of this study is to determine if acoltremon 0.003% can improve the frequency and severity of DED symptoms in CL wearers.

Study Start Date: Oct. 10

Study Type: INTERVENTIONAL

Condit...